| Systematic (IUPAC) name | |
|---|---|
| 3-(2-ethyltetrazol-5-yl)-1-methyl-5,6-dihydro-2H-pyridine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 120241-31-8 |
| ATC code | None |
| PubChem | CID 178030 |
| ChemSpider | 154980 |
| UNII | 4XFD7B36M6 |
| ChEMBL | CHEMBL131428 |
| Chemical data | |
| Formula | C9H15N5 |
| Mol. mass | 193.25 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Alvameline (Lu 25-109) is a M1 receptor agonist and M2/M3 receptor antagonist[1] that was under investigation for the treatment of Alzheimer's disease, but produced poor results in clinical trials[2] and was subsequently discontinued.
|
|||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)